Har-Vardi I, Gopas J, Rager-Zisman B, Hammerling G J, Segal S, Aboud M
Department of Microbiology and Immunology, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel.
Invasion Metastasis. 1992;12(5-6):301-8.
In previous studies, we have demonstrated that the highly metastatic IE-7 cell clone, derived from the T-10 fibrosarcoma, expressed both the H-2Dk and H-2Db genes, whereas a nonmetastatic IC-9 clone, derived from the same tumor, expressed only H-2Db, suggesting that the H-2Dk product might be involved in the metastatic phenotype. To substantiate this notion, IC-9 cells were transfected with an H-2Dk-expressing vector. Although all of the 4 randomly selected transfectant subclones elicited high H-2Dk expression, only one was as metastatic as IE-7 cells. This metastatic transfectant resembled IE-7 cells also in its inability to evoke CTL response in syngeneic mice, whereas the other transfectants were quite competent in this respect. It thus appears that the H-2Dk product may contribute to the metastatic phenotype provided that it is immunogenically abnormal. In addition, the present study provides evidence to suggest that lack of production of the tissue inhibitor of metalloproteinases TIMP-1/TIMP-2 is another important determinant in the metastatic phenotype of these cells.
在先前的研究中,我们已证明,源自T-10纤维肉瘤的高转移性IE-7细胞克隆表达H-2Dk和H-2Db基因,而源自同一肿瘤的非转移性IC-9克隆仅表达H-2Db,这表明H-2Dk产物可能与转移表型有关。为证实这一观点,用表达H-2Dk的载体转染IC-9细胞。尽管随机选择的4个转染子亚克隆均引发了高H-2Dk表达,但只有一个与IE-7细胞一样具有转移性。这个转移性转染子在同基因小鼠中也无法引发CTL反应,这一点与IE-7细胞相似,而其他转染子在这方面则相当有能力。因此,似乎H-2Dk产物可能有助于转移表型,前提是它在免疫原性上异常。此外,本研究提供的证据表明,金属蛋白酶组织抑制剂TIMP-1/TIMP-2的缺乏是这些细胞转移表型的另一个重要决定因素。